Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brachytherapy, Radioisotope”

523 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 523 results

Testing effectiveness (Phase 2)UnknownNCT02565927
What this trial is testing

A Trail of a Novel Tracheal Radioactive Stent for the Malignant Airway Obstruction

Who this might be right for
Malignant Airway Obstruction
Zhongda Hospital 60
Early research (Phase 1)WithdrawnNCT03111069
What this trial is testing

Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children

Who this might be right for
Malignant Neoplasms of Mesothelial and Soft TissueRhabdomyosarcoma, PelvicRhabdomyosarcoma, Abdominal
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00379665
What this trial is testing

Intratumoral Cancer Chemotherapy Through a Flexible Bronchoscope as an Adjunct to Brachytherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Southwestern Regional Medical Center 25
Large-scale testing (Phase 3)UnknownNCT00402519
What this trial is testing

APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer

Who this might be right for
Breast Cancer
University of Erlangen-Nürnberg Medical School 1,300
Testing effectiveness (Phase 2)Study completedNCT01227642
What this trial is testing

Using Ultrasound Spectrum Analysis (USA) to Guide Dose Escalated Prostate Brachytherapy

Who this might be right for
Clinical Stage T2b or Less of Prostate CancerProstate BrachytherapyTransrectal Prostate Ultrasound Treatment Planning
Beth Israel Medical Center 14
Not applicableLooking for participantsNCT07631572
What this trial is testing

Cs-131LDR Brachytherapy for Organ-Preserving Irradiation for Recurrent Cervical and Endometrial Cancer

Who this might be right for
Gynecologic Cancer
Denise Fabian 10
Not applicableUnknownNCT04967495
What this trial is testing

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 171
Testing effectiveness (Phase 2)Study completedNCT00807300
What this trial is testing

Computed Tomography (CT) - Guided Brachytherapy Versus Transarterial Chemoembolization in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Magdeburg 77
Testing effectiveness (Phase 2)Looking for participantsNCT03541928
What this trial is testing

Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & Surgery

Who this might be right for
High-risk Prostate CancerProstate Cancer
The Methodist Hospital Research Institute 60
Not applicableStudy completedNCT02618161
What this trial is testing

Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment

Who this might be right for
Prostate Cancer
Mid and South Essex NHS Foundation Trust 100
Large-scale testing (Phase 3)Active Not RecruitingNCT02505750
What this trial is testing

Safety of a Boost (CXB or EBRT) in Combination With Neoadjuvant Chemoradiotherapy for Early Rectal Adenocarcinoma

Who this might be right for
Rectal Neoplasms
Centre Antoine Lacassagne 148
Not applicableEnded earlyNCT03324958
What this trial is testing

VIrtual REality Glasses for the Enhancement of Acute BRACHYtherapy Tolerance for Endometrial Cancer Patients.

Who this might be right for
Endometrial Cancer
Centre Hospitalier Universitaire de Saint Etienne 24
Large-scale testing (Phase 3)Not Yet RecruitingNCT06855589
What this trial is testing

Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.

Who this might be right for
Prostate Cancer (Adenocarcinoma)
Charles LeMoyne Hospital 400
Not applicableStudy completedNCT00165126
What this trial is testing

Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma

Who this might be right for
Endometrial CarcinomaCervix CancerCarcinoma of the Uterus
Dana-Farber Cancer Institute 40
Not applicableStudy completedNCT03243825
What this trial is testing

Comparative Study of Different Neoadjuvant Therapies Before Radical Hysterectomy in Stage Ib2-IIa2 Cervical Cancer

Who this might be right for
Cervical Cancer
Chinese Academy of Medical Sciences 120
Not applicableUnknownNCT04278443
What this trial is testing

Fertility After Prostate Brachytherapy

Who this might be right for
Prostate Cancer
East and North Hertfordshire NHS Trust 40
Not applicableNot Yet RecruitingNCT07327515
What this trial is testing

PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors

Who this might be right for
Malignant Tumors
Li Min 90
Large-scale testing (Phase 3)Study completedNCT01174017
What this trial is testing

Ability of a New Design of Iodine 125 Seed to Maintain Intended Position When Implanted in the Prostate

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 41
Testing effectiveness (Phase 2)Study completedNCT01639625
What this trial is testing

Concurrent Treatment of Squamous Cell Carcinoma or Adenocarcinoma of the Cervix With CIGB-300 for Local Application

Who this might be right for
Squamous Cell Carcinoma of the CervixAdenocarcinoma of the Cervix
Laboratorio Elea Phoenix S.A. 18
Not applicableActive Not RecruitingNCT06087718
What this trial is testing

Feasibility of the Maastro Applicator in Rectal Cancer

Who this might be right for
Rectal CancerFeasibilityToxicity+5 more
Maastricht Radiation Oncology 10
Next Page